rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression
RecruitingNCT06511544Phase: NAStarted 2024-01-02
Summary
The goal of this clinical trial is to learn if Transcranial Magnetic Stimulation (TMS) to part of the brain called the ventromedial prefrontal cortex (VMPFC) can treat a symptom called rumination in a
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
70 Years
Locations
Goodman Hall Neuroscience CenterIndianapolis, Indiana, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06511544